The new area of regenerative medicine addressing joint and connective tissue damage is called Orthobiologics.
Regenerative injection techniques are treatments using stem cells and growth factors, placenta tissue matrix and tissue cytokines from human cell and tissue products (HCT/P)-which greatly improve the rate and effectiveness for the treatment of injured joint, ligament, tendon and bone.
Within this medical specialty Dr Davison is currently applying the use of umbilical sourced growth factors and mesenchymal stem cells (MSC) from one of the leading biotech companies in the US.
Dr. Kevin Davison has the most experience with Orthobiologic procedures in the State of Hawaii and Pacific Rim.
Dr Kevin Davison, clinical director of Maui Regenerative Medicine since 1989, has been utilizing Orthobiologic techniques for more than two decades. He was the first to use platelet rich plasma (PRP) for orthopedics in Hawaii and continues to set the standard for all orthopedic regenerative treatments. He is the first physician to use mesenchymal stem cells in the State. Dr Davison has instructed other doctors in RIT techniques since 2006 and currently runs teaching seminars (https://prolotherapytrainings.com) in the Pacific Northwest and Hawaii.
Dr Davison has been using autologous (from the patient) fat derived stem cells since 2013. Treatment of worn knees, hips, shoulders, and ankles was very successful. Yet there were a few conditions that were not responding as well. Bone on bone arthritis was one.
Through research and experience he found that in older individuals, autologous stem cells had two distinct disadvantages:
- Stem cells and the tissue growth factors-the viability and quantity were an issue.
- Lack of scaffolding cytokines-structural components for collagen regeneration.
This was solved through the discovery of perinatal growth factors, stem cells (umbilical cord derived stem cells) and placenta matrix growth factors.
Umbilical stem cells are nature’s most vital source of mesenchymal stem cells. They contain potent growth factors, cytokines, signaling proteins and much more.
They are very effective in eliminating inflammation and regenerating collagen of damaged joints ligaments and tendons. In addition, they are “immune privileged”. Which means they do not create an immune reaction from the recipient.
We are currently administering products from one of the leaders in this field-Predictive Biotech.
Who is Predictive Biotech and what were they established to do? :
To be the leader in procuring, processing and distributing allogenic Human Cell and Tissue Products (HCT, Ps) for regenerative medicine. Advance the research of HCT/P for regenerative medicine.
Predictive Biotech is one of the first biotech companies to provide clinicians with viable (HCT, Ps) and is committed to truth, trust and transparency.
Human Cell & Tissue Product
Predictive insists on rigorous research on every product they develop. They take the extra steps to identify the optimal tissue source from which to derive human cell and tissue products to better support the body’s natural regenerative process and aid in its repair.
As we know over time, healthy tissue can become dysfunctional due to age and injury. A human cell or tissue product (HCT, Ps) is administered to a recipient to repair, reconstruct, replace or supplement the same basic functions of the recipient’s cells or tissues.
Predictive Biotech’s human cell and tissue allografts supplement similar tissues in your body via scaffolding, growth factors, general and homeostatic cytokines.
A more detailed analysis of the main growth factors found in different Orthobiologic sources. You should notice the checks represent the presence and relative amounts of these cytokine/growth factors.